Tag: biosimilars
Insurance Changes and Generic Switching: Navigating Formulary Updates in 2025
Learn how 2025 Medicare Part D formulary changes are forcing generic and biosimilar switches - and what you can do to protect your medication access and avoid costly surprises.
Addressing Patient Concerns About Biosimilars: Reducing Hesitation and Building Trust
Biosimilars offer major cost savings and proven safety, but patient hesitation holds them back. Learn why people are unsure, how to talk about them honestly, and what’s changing in 2025 to build trust.